Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern

Archives of Dermatology

Volumn 148, Issue 4, 2012, Pages 497-502

  Ezzedine, Khaled ^a,b   Diallo, Abou ^a   Léauté Labrèze, Christine ^a,b   Seneschal, Julien ^a,b   Mossalayi, Djavad ^b   AlGhamdi, Khalid ^c   Prey, Sorilla ^a,b   Bouchtnei, Serge ^a   Cario André, Muriel ^b   Boralevi, Franck ^a,b   Jouary, Thomas ^a,b   Taieb, Alain ^a,b  

^a HÔPITAL SAINT ANDRÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; FOOT DISEASE; HAIR DISCOLORATION; HALO NEVUS; HAND DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ONSET AGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STAGING; TRUNK; VITILIGO;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGING, PREMATURE; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; FEMALE; HAIR COLOR; HUMANS; INFANT; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEVUS, HALO; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VITILIGO; YOUNG ADULT;

EID: 84857540993     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.351     Document Type: Article

References (26)

1. Sutton RL. An unusual variety of vitiligo (leukoderma acquisitum centrifugum). J Cutan Dis. 1916;34:797-800.
2. Frank SB, Cohen HJ. The halo nevus. Arch Dermatol. 1964;89:367-373.
3. Brazzelli V, Larizza D, Martinetti M, et al. Halo nevus, rather than vitiligo, is a typical dermatologic finding of Turner's syndrome: clinical, genetic, and immunogenetic study in 72 patients. J Am Acad Dermatol. 2004;51(3):354-358. (Pubitemid 39178660)
4. Larsson PA, Lidén S. Prevalence of skin diseases among adolescents 12-16 years of age. Acta Derm Venereol. 1980;60(5):415-423. (Pubitemid 11225016)
5. Wayte DM, Helwig EB. Halo nevi. Cancer. 1968;22(1):69-90.
6. Jouary T, Taieb A. Halo nevi and vitiligo. In: Taieb A, Picardo M, eds. Vitiligo. Berlin, Germany: Springer-Verlag; 2010:61-64.
7. Barona MI, Arrunátegui A, Falabella R, Alzate A. An epidemiologic case-control study in a population with vitiligo. J Am Acad Dermatol. 1995;33(4):621-625.
8. van Geel N, Vandenhaute S, Speeckaert R, et al. Prognostic value and clinical significance of halo naevi regarding vitiligo. Br J Dermatol. 2011;164(4):743-749.
9. Taïeb A, Picardo M; VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007; 20(1):27-35. (Pubitemid 46090162)
10. Ezzedine K, Gauthier Y, Léauté-Labrèze C, et al. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients [published online ahead of print May 24, 2011]. J Am Acad Dermatol. doi: 10.1016/j.jaad.2010.08.031. Accessed June 14, 2011.
11. de Vijlder HC, Westerhof W, Schreuder GM, de Lange P, Claas FH. Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res. 2004;17(3):270-274. (Pubitemid 38724557)
12. van Geel N, Speeckaert R, Lambert J, et al. Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis [published online ahead of print June 23, 2011]. J Eur Acad Dermatol Venereol. doi:10.1111/j.1468-3083. 2011 .04160.x. Accessed July 12, 2011.
13. Jin Y, Birlea SA, Fain PR, et al. Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset. J Invest Dermatol. 2011;131(6):1308-1312. doi:10.1038/jid.2011.12.
14. Coleman WP III, Gately LE III, Krementz AB, Reed RJ, Krementz ET. Nevi, lentigines, and melanomas in blacks. Arch Dermatol. 1980;116(5):548-551. (Pubitemid 10101707)
15. Pack GT, Davis J, Oppenheim A. The relation of race and complexion to the incidence of moles and melanomas. Ann N Y Acad Sci. 1963;100:719-742.
16. Lewis MG, Johnson K. The incidence and distribution of pigmented naevi in Ugandan Africans. Br J Dermatol. 1968;80(6):362-366.
17. Chedekel MR, Smith SK, Post PW, Pokora A, Vessell DL. Photodestruction of pheomelanin: role of oxygen. Proc Natl Acad Sci U S A. 1978;75(11):5395-5399. (Pubitemid 9079801)
18. Chedekel MR, Agin PP, Sayre RM. Photochemistry of pheomelanin: action spectrum for superoxide production. Photochem Photobiol. 1980;31:553-555. (Pubitemid 10054478)
19. De Leeuw SM, Smit NP, Van Veldhoven M, et al. Melanin content of cultured human melanocytes and UV-induced cytotoxicity. J Photochem Photobiol B. 2001; 61(3):106-113. (Pubitemid 32851411)
20. Samokhvalov A, Hong L, Liu Y, et al. Oxidation potentials of human eumelanosomes and pheomelanosomes. Photochem Photobiol. 2005;81(1):145-148. (Pubitemid 40327571)
21. Takeuchi S, Zhang W, Wakamatsu K, et al. Melanin acts as a potent UVB photosensitizer to cause an atypical mode of cell death in murine skin. Proc Natl Acad Sci U S A. 2004;101(42):15076-15081. (Pubitemid 39391721)
22. Smit NP, Vink AA, Kolb RM, et al. Melanin offers protection against induction of cyclobutane pyrimidine dimers and 6-4 photoproducts by UVB in cultured human melanocytes. Photochem Photobiol. 2001;74(3):424-430.
23. Van Neste D, Tobin DJ. Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging. Micron. 2004;35(3):193-200. (Pubitemid 38225245)
24. Falabella R. Hair involvement in vitiligo. In: Taieb A, Picardo M, eds. Vitiligo. Berlin, Germany: Springer-Verlag; 2010:65-71.
25. Jin Y, Birlea SA, Fain PR, et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med. 2010;362(18):1686- 1697.
26. van Geel NA, Mollet IG, De Schepper S, et al. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigment Cell Melanoma Res. 2010;23(3): 375-384.